Innoprot is a biotechnology company established in 2007 as a spin-off from the University of the Basque Country. Innoprot provides products and technologies for multiplexing cell-based assays in drug discovery and development, including primary cells, immortalized cell lines and recombinant cell lines. With a proprietary technology for GPCR screening, Innoprot is able to identify the compounds with the highest effectiveness but avoiding the undesired side effects.

Innoprot also acts as a C.R.O. providing screening services focused on GPCRs, Fibrosis and Neurodegenerative diseases like Alzheimer’s Disease, Parkinson’s Disease or ALS.

Innoprot’s personal staff combines experience in the field of drug discovery technologies with broad career path as pharmaceutical services providers.